In this context, future epidemiological research is necessary to characterize obesity phenotypes through the measurement and establishment of specific cut-off points for widely studied adipokines, such as leptin or adiponectin, in order to have a more refined diagnosis of those people at risk of developing metabolic abnormalities beyond anthropometric evaluation. Here, ADIPOQ is linked to obesity disorder.